"Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q" by David B. Dix, Conrad V. Fernandez et al.
 

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

Document Type

Journal Article

Publication Date

10-20-2019

Journal

Journal of Clinical Oncology

Volume

37

Issue

30

Inclusive Pages

2769-2777

DOI

10.1200/JCO.18.01972

Peer Reviewed

1

Find in your library

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 45
  • Usage
    • Abstract Views: 4
  • Captures
    • Readers: 44
see details

Share

COinS